Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)
ted.europa.eu
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varel...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 1, 2027
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-01
TEN
Spain – Site-clearance work – Obras de conservación y limpieza de arroyos en los tramos que discurren por suelo urbano en el término municipal del Ayuntamiento de Piélagos.
ted.europa.eu
Buyer: Alcaldía del Ayuntamiento de Piélagos | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-06-01
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 1, 2027
Buyer: Alcaldía del Ayuntamiento de Piélagos | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027-06-01
TEN
Spain – Prepared meals – Suministro de paellas y platos preparados del Ayuntamiento de Piélagos.
ted.europa.eu
Buyer: Alcaldía del Ayuntamiento de Piélagos | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-01
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 1, 2027
Buyer: Alcaldía del Ayuntamiento de Piélagos | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-01
TEN
France – Motor vehicles – Système d'acquisition dynamique pour la fourniture et livraison de véhicules, engins et matériels divers neufs pour le Département de la Somme.
ted.europa.eu
Buyer: Département de la Somme | Notice type: cn-standard | Procedure: oth-mult | Contract: supplies | Deadline: 2027-06-01
TenderProcurement ContractFranceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 1, 2027
Buyer: Département de la Somme | Notice type: cn-standard | Procedure: oth-mult | Contract: supplies | Deadline: 2027-06-01
GRA
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
grants.gov
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interv...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 2, 2027
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions using a milestone-driven, biphasic award mechanism, R61/R33 Phased Innovation Award. Specifically, this NOFO solicits applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. The first phase, funded by the R61, will providing for up to 2 years to identify unique host biological patterns (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with heterogeneity of probiotic clinical effects using observational or se...
GRA
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
grants.gov
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interv...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 2, 2027
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. This NOFO will support studies to assess the ability of the unique patterns of host biology (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with probiotic usage to detect the improvement of probiotic responsiveness. Well-suited applications must offer rigorously designed mechanistic studies using relevant/innovati...
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Budesonid, ATC A07EA06
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tofacitinib, ATC L04AF01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol, Glycopyrroniumbromid und Beclometason, ATC R03AL09
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Peginterferon beta-1a, ATC L03AB13
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Epinephrin, ATC C01CA24
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Erythropoietin zeta, ATC B03AX01
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tolvaptan, ausgenommen Arzneimittel mit einheitlichen Wirkstärken, ATC G04BX21
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
TEN
France – Vascular prostheses – Fourniture d’« IMPLANTS D’EMBOLISATION NEUROLOGIQUES ET PERIPHERIQUES (coïls, spirales libres, microsphères chargeables, agents emboliques liquides) et CATHETERS-GUIDES & INTRODUCTEURS LONGS DE NEURORADIOLOGIE
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 5, 2027
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TEN
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-Westfalen
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TEN
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-Westfalen
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TEN
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ponesimod, ATC L04AE04 für die Zeit 01.08.2025 - 31.07.2027
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-Westfalen
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Certolizumab pegol, ATC L04AB05 für die Zeit 01.08.2025 - 31.07.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Melatonin (ausschließlich 1mg und 5mg), ATC N05CH01 für die Zeit 01.08.2025 - 31.07.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tralokinumab, ATC D11AH07 für die Zeit 01.08.2025 - 31.07.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Eisen(III)-Derisomaltose, ATC B03AC08 für die Zeit 01.08.2025 - 31.07.2027
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
38976
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-01
38977
Spain – Site-clearance work – Obras de conservación y limpieza de arroyos en los tramos que discurren por suelo urbano en el término municipal del Ayuntamiento de Piélagos.Buyer: Alcaldía del Ayuntamiento de Piélagos | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2027...
Tender
Procurement Contract
Spain
Not provided on the source page. Please check the official source.
Buyer: Alcaldía del Ayuntamiento de Piélagos | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-01
38979
France – Motor vehicles – Système d'acquisition dynamique pour la fourniture et livraison de véhicules, engins et matériels divers neufs pour le Département de la Somme.Buyer: Département de la Somme | Notice type: cn-standard | Procedure: oth-mult | Contract: supplies | Deadline: 2027-06-01
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: Département de la Somme | Notice type: cn-standard | Procedure: oth-mult | Contract: supplies | Deadline: 2027-06-01
38980
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precis...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions using a milestone-driven, biphasic award mechanism, R61/R33 Phased Innovation Award. Specifically, this NOFO solicits applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. The first phase, funded by the R61, will providing for up to 2 years to identify unique host biological patterns (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with heterogeneity of probiotic clinical effects using observational or secondary data analysis studies. The second phase, funded under the R33, will support studies to assess the ability of the unique patterns determined in the R61 phase to detect the improvement of probiotic responsiveness in rigorously designed mechanistic studies in relevant animal models or in human subjects. The combined R61/R33 should not exceed 5 years. Transition from the R61 to the R33 phase of the award will be administratively reviewed and will be determined based on successful completion of Transition Milestones that need to be clearly specified in the R61 phase application. Support for...
38981
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precis...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. This NOFO will support studies to assess the ability of the unique patterns of host biology (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with probiotic usage to detect the improvement of probiotic responsiveness. Well-suited applications must offer rigorously designed mechanistic studies using relevant/innovative animal models or in human subjects. This NOFO is intended to support projects where potential host biological patterns that are correlated with probiotic usage have been identified, as demonstrated with supportive preliminary data, but require further mechanistic studies to test for their causality or predictability. Applicants pursuing early-stage research to identify host biological patterns that may affect probiotic health outcomes should consider the companion (R61/R33) NOFO PAR-AT-24-XXX (TEMP-25412).
38982
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brinzolamid und Brimonidin, ATC S01EC24Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-03
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-VerfahrensBuyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
38992
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-WestfalenBuyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
38993
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-WestfalenBuyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Medical aids – Offene Rahmenvereinbarung über Rabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell, für die Blutzuckerteststreifen für das Bundesland Nordrhein-WestfalenBuyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Melatonin (ausschließlich 1mg und 5mg), ATC N05CH01 für die Zeit 01.08.2025 - 31.07.2027Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
